Business
Cytophage Receives Federal Support for Entry into European Market through France Biomanufacturing Mission
(TheNewswire) WINNIPEG – TheNewswire - September 29, 2025 — C...
About this update from Cytophage Technologies Ltd.
[{"type":"text","content":"Cytophage Receives Federal Support for Entry into European Market through France Biomanufacturing Mission\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n WINNIPEG –\n \n\n TheNewswire\n-\n \n\n September 29, 2025 — Cytophage Technologies\nLtd. (“Cytophage” or the “Company”) (TSXV: CYTO, FSE: 70G)\nannounced its participation in the Canadian biomanufacturing mission\nheld in Lyon and Paris, France from September 21-25, 2025 under the\nCanadian International Innovation Program (CIIP). This government-led\ninitiative, organized by Global Affairs Canada and the National\nResearch Council of Canada,\n \n\n brought together\nleading Canadian companies to explore co-innovation opportunities\nwithin the French bioeconomy.\n \n\n\n\n “We engaged with prospective European partners on\nthis mission to help advance the commercialization of our\nbacteriophage products globally,” said Dr. Steven Theriault, CEO of\nCytophage. “We were honoured to represent Canadian innovation\nalongside our esteemed industry peers, and grateful for the federal\ngovernment’s support for this mission.\n \n\n We\nextend our sincere thanks to the Trade Commissioner Service | Service\ndes délégués commerciaux of Canada and the Canadian International\nInnovation Program (CIIP) for making this initiative\npossible.\n \n\n ”\n \n\n\n\n Participation in this mission allowed Cytophage to\nshowcase its innovative bacteriophage products for human and animal\nhealth, most notably at the 10th Bioproduction Congress in Lyon,\nFrance which is Europe’s premier biopharmaceutical manufacturing\nevent\n \n\n . The Company’s participation included\none-on-one meetings and numerous networking opportunities aimed at\nestablishing new biomanufacturing partnerships, and accelerating the\nCompany’s entry into the EU market. The program also featured\nhigh-level visits with French industry leaders, University Hospitals\nand innovation clusters.\n \n\n\n\n Cytophage will advance discussions with leading\nEuropean animal health companies regarding distribution opportunities\nfor its animal health bacteriophage products following the recent\ncompletion of successful pilot studies in Europe (\n \n\n\n see September 23, 2025 press\nrele...